Teleflex Incorporated (NYSE:TFX) Stake Lifted by Oak Thistle LLC

Oak Thistle LLC raised its stake in Teleflex Incorporated (NYSE:TFX) by 243.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 10,695 shares of the medical technology company’s stock after buying an additional 7,585 shares during the quarter. Teleflex accounts for approximately 0.6% of Oak Thistle LLC’s holdings, making the stock its 29th biggest holding. Oak Thistle LLC’s holdings in Teleflex were worth $1,903,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Janus Henderson Group PLC increased its holdings in shares of Teleflex by 2.8% in the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after acquiring an additional 147,147 shares during the period. State Street Corp increased its stake in shares of Teleflex by 1.0% in the third quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock valued at $508,757,000 after purchasing an additional 21,291 shares during the period. Geode Capital Management LLC increased its stake in shares of Teleflex by 0.5% in the third quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock valued at $278,676,000 after purchasing an additional 5,746 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in shares of Teleflex by 0.4% during the third quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company’s stock valued at $105,749,000 after buying an additional 1,884 shares during the last quarter. Finally, Point72 Asset Management L.P. boosted its position in shares of Teleflex by 31.2% during the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock worth $100,768,000 after buying an additional 96,958 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Price Performance

Shares of Teleflex stock opened at $179.00 on Wednesday. Teleflex Incorporated has a 52 week low of $171.69 and a 52 week high of $256.85. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock has a market cap of $8.31 billion, a PE ratio of 35.59, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. The company’s 50-day moving average price is $185.27 and its two-hundred day moving average price is $216.16.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $764.40 million for the quarter, compared to analysts’ expectations of $768.68 million. During the same quarter in the previous year, the company posted $3.64 EPS. The business’s revenue was up 2.4% compared to the same quarter last year. As a group, sell-side analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Stockholders of record on Friday, November 15th were given a dividend of $0.34 per share. The ex-dividend date was Friday, November 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.76%. Teleflex’s dividend payout ratio (DPR) is presently 27.04%.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. Royal Bank of Canada lowered their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Mizuho reduced their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Finally, Truist Financial reduced their price target on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $252.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.